PS071 Vascular and Metabolic Effects of Ezetimibe Depend on Dosages of Simvastatin in Patients with Hypercholesterolemia
Ezetimibe demonstrates decreasing visceral fat and improving insulin sensitivity in animals and humans. We first reported simvastatin dose-dependently worsens insulin sensitivity.
Source: CVD Prevention and Control - Category: Global & Universal Authors: K. Koh, S. Han Tags: Poster Abstract Source Type: research
More News: Insulin | International Medicine & Public Health | Simvastatin | Statin Therapy | Vytorin | Zetia | Zocor